Insulet Corporation Competitors, Revenue, Alternatives and Pricing

Claim your profile


Boston, MA USA
Total Funding:N/A
Industry:Medical Equip
Lead Investor(s):Deerfield Management Company

Estimated Revenue & Financials

  • Insulet Corporation's estimated annual revenue is currently $322M per year.
  • Insulet Corporation received $340.2M in venture funding in November 2017.
  • Insulet Corporation's estimated revenue per employee is $251,000

Employee Data

  • Insulet Corporation has 1283 Employees.
  • Insulet Corporation grew their employee count by 20% last year.
  • Insulet Corporation currently has 94 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
Missing a competitor? Contribute!?

About Insulet Corporation: Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnpod technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 100,000 users across the globe rely on Insulet's Omnipod Insulin Management System to bring simplicity and freedom to their lives. For more information, please visit:, and* *Starting July 1, 2018, Insulet will assume direct distribution of its Omnipod Insulin Management System in Europe, including sales, marketing, training and customer support activities. This will allow Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long term, as it already does in the United States and Canada.

keywords:Biotechnology,Healthcare,Medical Devices


Number of Employees


Revenue (est)


Current Jobs


Employee Growth %


Total Funding







Insulet Corporation News

14-Sep-19 - Assessing If Insulet Corporation Has Started An Intermediate ...

Shares of Insulet Corporation (PODD) (The Insulin Provider) for example have been on a relentless rally since they bottomed in 2009.

11-Sep-19 - Insulet Corporation's Convertible Senior Notes Offering

The Insulet Corporation offer is $800 million principal amount of 0.375% convertible senior notes due 2026, including $100 million principal ...

12-Sep-19 - Checklist Stock of the Day : Insulet Corporation (PODD)

Insulet Corporation (PODD):. If you are considering getting into the day trading or penny stock market, it's a legitimate and profitable method for ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing

Insulet Corporation Funding

DateAmountRoundLead InvestorsReference
2002-10-07$22.0MSpending On: UndisclArticle
2004-03-03$35.5MUndisclosedAlta PartnersArticle
2006-02-17$50.0MUndisclosedThe Federated Kaufman FundArticle
2009-03-17$60.0MUndisclosedDeerfield Management CompanyArticle

Insulet Corporation Executive Hires

2004-07-21Jeff SmithVP Sales and MarketingArticle
2004-09-14Shawna GvazdauskasVP SalesArticle
2006-03-24Ruthann DePietroVP Quality/Reg AffArticle
2006-06-09Carsten BoessCFOArticle
2007-02-16Luis MalaveChief Operating OfficerArticle
2008-09-04Bill ArthurVP Business DevelopmentArticle
2009-08-18Peter DevlinChief Commercial OfficerArticle
2011-01-11Charles LiamosCOOArticle
2013-01-24Tracey H. WielinskiVP Global Regulatory/Clinical Affairs/Article
2014-01-22Patrick RyanCOOArticle
2014-09-17Patrick J. SullivanPresident/CEO/DirectorArticle
2014-11-06Allison DorvalCFOArticle
2016-03-17Aiman Abdel-MalekSVP/Advanced Technology EngineeringArticle
2016-09-07Trang LyVP/Medical DirectorArticle
2017-05-31Bret ChristensenChief Commercial OfficerArticle

Insulet Corporation New Location/Offices